Nicolas Donoso

CEO at SAVAL

Nicolas Donoso has a diverse and extensive work experience. Nicolas most recently served as the CEO of Saval Pharmaceuticals since October 2020. Prior to that, they worked as the CEO of Colmena from November 2016 to September 2020. Nicolas also held the position of CFO at Colmena Salud from January 2015 to October 2016. Before their time at Colmena, they worked as the Business Development Manager at Bethia S.A. from February 2013 to December 2014. Prior to that, they were an Engagement Manager at McKinsey & Company from August 2009 to February 2013. Their early work experience includes a role as a Supply Chain Manager at Bethia/Parmalat/Danone from August 2004 to May 2007.

Nicolas Donoso's education history includes a Master of Business Administration (MBA) degree from the University of California, Berkeley, Haas School of Business, which they pursued from 2007 to 2009. Prior to that, from 1998 to 2002, they studied Engineering and obtained a Bachelor of Science (B.S.) degree from Pontificia Universidad Católica de Chile. Additionally, it is known that they attended Andree English School, although the specific dates and details about the degree or field of study are not provided.

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


SAVAL

3 followers

Innovation and creativity have been evident since the creation of SAVAL Pharmaceuticals. The way to focus on our work has enabled us to build an organization which possesses the necessary flexibility to adapt the different stages in our history, this being the reason why our customers clearly perceive the continuing leadership of SAVAL in the market. Our company has always complied with the varied pharmacological needs permanently in demand by our customers. This is the hub of our Corporate Mission.


Industries

Headquarters

Santiago, Chile

Employees

1,001-5,000

Links